Skip to main content

Table 2 Number of BZDA prescriptions at baseline and at 1-month, 6-month, and 3-year follow-ups grouped by the BZDA used at baseline and withdrawal status data at 3-year follow-up (non-users, irregular users, and regular BZDA users)

From: Long-term persistence of withdrawal of temazepam, zopiclone, and zolpidem in older adults: a 3-year follow-up study

   Zopiclone Zolpidem Temazepam Other BZDA Total BZDA users
Non-users of any BZDA Irregular Regular Irregular Regular Irregular Regular Irregular Regular  
N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Baseline (92) 0 (0) 0 (0) 52 (57) 0 (0) 26 (28) 0 (0) 14 (15) 0 (0) 0 (0) 92 (100)
1-month (90) 70 (78) 8 (9) 1 (1) 4 (4) 0 (0) 6 (7) 1 (1) 0 (0) 0 (0) 20 (22)
6-month (89) 34 (38) 25 (48) 6 (12) 12 (46) 2 (8) 7 (50) 3 (21) 0 (0) 0 (0) 55 (62)
3-year (83) 26 (31) 14 (27) 15 (29) 5 (19) 10 (38) 6 (43) 5 (36) 7a (8) 1b (1) 57 (69)
  1. aoxazepam (N = 4), alprazolam (N = 1), diazepam (N = 1) and clonazepam (N = 1)
  2. bchlordiazepoxide with amitriptyline combination preparation (N = 1)